COMBINATIONS AND USES THEREOF

Abstract: the present disclosure describes a pharmaceutical combination of an anti-cd19 antibody and a phosphoinositide 3-kinase inhibitor for the treatment of non-hodgkin's lymphoma, chronic lymphocytic leukemia and/or acute lymphoblastic leukemia.

Inventor(s): Jan Endell, Mark Winderlich, Rainer Boxhammer

CPC Classification: A61K39/39558 (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms ; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles ; soap compositions ))

Search for rejections for patent application number 20250195646